https://www.selleckchem.com/pr....oducts/sulfatinib.ht
r clinicians to prognosticate and plan subsequent treatments for patients with advanced NSCLC harbouring EGFR mutations. With the gradual increase in the incidence of thyroid cancer, people's attention to thyroid cancer has also gradually increased. Although the prognosis of thyroid cancer is rather mild compared to other cancers, it will still bring a heavy psychological burden on people who have been diagnosed. At present, the diagnosis of thyroid cancer mainly depends on ultrasound and percutaneous fine needle aspiration (pFNA). D
Like
Comment
Share
